Benzinga
23 Sept 2025, 12:16 UTC · 51w ago
Verdict
Headline leans bearish. We score FLY −1.00 across three claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
3 claims · scored −1 bearish … +1 bullish
Scholar Rock Holding Corp (SRRK) received an FDA Complete Response Letter for Apitegromab in Spinal Muscular Atrophy due to facility observations at Catalent Indiana.
So whatAn FDA Complete Response Letter is a major regulatory setback that delays or prevents drug approval, directly impacting the company's valuation.
More negative than 98% of claims this week
Firefly Aerospace (FLY) reported a Q2 loss of $5.78 per share and a decline in sales to $15.549 million from $21.071 million year-over-year.
Continue reading
5 related stories
More negative than 96% of ticker scores this week
Scored by the NIS engine · methodology.
More negative than 92% of claims this week
Faraday Future announced a $41 million investment in Qualigen Therapeutics (QLGN).
More positive than 84% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
Shares fell sharply after reporting a wider loss per share and declining sales in Q2.
More negative than 96% of ticker scores this week
Shares dipped 17.7% in pre-market trading.
More negative than 96% of ticker scores this week
Shares dipped 6.3% following negative commentary from a hedge fund manager.
More negative than 96% of ticker scores this week
Shares declined 14.1% in pre-market trading.
More negative than 96% of ticker scores this week
Shares fell 14.3% after receiving an FDA Complete Response Letter for Apitegromab.
More negative than 82% of ticker scores this week
Shares fell 6.1% in pre-market trading.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
1h ago
−59.0%
Price agrees with the score
$20.28 vs $49.52 close before publication (Sep 22) · not market-adjusted
FLY chart →
